Pfizer sees emergency use filing for Covid-19 vaccine after U.S. election

Pfizer said on Friday it would apply for emergency use in the U.S. of its Covid-19 vaccine candidate as soon as a safety milestone is achieved in the third week of November.


Leave a Reply

Your email address will not be published. Required fields are marked *